A Post-Authorisation Safety Study Patient Registry of patients with high-risk neuroblastoma being treated with the monoclonal antibody dinutuximab beta (EUSA DB 0001) First published 31/10/2019 Last updated 08/07/2024 EU PAS number:EUPAS31973 Study Ongoing